Morning Market Gainers

shares climbed 103.42 percent to $5.94 after the company agreed to be acquired by

for $6.00 per share, or $98 million.

shares jumped 45.38 percent to $2.88 as the company reported that its customer's TiGenix Phase 3 clinical trial has met primary endpoint.

shares surged 33.42 percent to $4.55 as the company reported additional data from VTI-208 presentation at the Rostock Conference.

shares rose 19.30 percent to $4.94 after the company reported that it has concluded recruitment of initial safety cohort of the SCiStar Phase 1/2a dose-escalation clinical trial of AST-OPC1 for complete cervical spinal cord injury.

shares gained 17.60 percent to $39.56 following the announcement of positive ALN-PCSsc study results.

shares rose 4.85 percent to $10.81. Analysts at JP Morgan initiated coverage of SunEdison with a Overweight rating.

rose 4.15 percent to $196.80 following announcement of the FDA Priority Review for obeticholic acid for the treatment of primary biliary cirrhosis.

shares climbed 2.68 percent to $79.30. Berkshire Hathaway disclosed $4.48 billion, or around 10.8 percent stake in Phillips 66.

shares gained 1.73 percent to $9.10. Deutsche Bank upgraded JC Penney from Hold to Buy and raised the price target from $10.00 to $12.00.